Showing 7331-7340 of 8649 results for "".
- Glaukos Receives FDA 510(k) Clearance of the iStent Infinitehttps://modernod.com/news/glaukos-receives-fda-510k-clearance-for-the-istent-infinite/2481013/Glaukos announced that it has received 510(k) clearance from the FDA for the iStent infinite Trabecular Micro-Bypass System. The iStent infinite is indicated for use in a standalone procedure to reduce elevated IOP in patients with primary open-angle glaucoma uncontrolled
- High-Tech Imaging Offers New Way to Detect Signs of Early Glaucomahttps://modernod.com/news/high-tech-imaging-offers-new-way-to-detect-signs-of-early-glaucoma/2481008/A new, noninvasive ocular imaging method may be able to detect an early indicator of glaucoma in time to prevent disease progression and vision loss, according to a new study from New York Eye and Ear Infirmary of Mount Sinai (NYEE). The study was published in the July/August issue of Op
- Phase 4 Paladin Study Confirms Safety of Iluvien Treatment and Reduced Burden of Care For DME Patientshttps://modernod.com/news/paladin-phase-4-study-confirms-safety-of-durable-iluvien-treatment-and-reduces-burden-of-care-for-dme-patients/2480992/Alimera Sciences announced that the PALADIN phase 4 study confirms the safety of Iluvien (fluocinolone acetonide intravitreal implant) 0.19 mg sustained release intravitreal implant and provides a durable treatment option that reduces the frequency of recurrence for patients wit
- Bausch + Lomb CEO Joseph C. Papa to Step Downhttps://modernod.com/news/joseph-c-papa-to-step-down-from-ceo-role-at-bausch-lomb/2480983/Bausch + Lomb announced Joseph C. Papa has stepped down as chair of the Board of Directors and plans to step down as CEO. The board appointed Thomas W. Ross, Sr., to serve as the chair, and has begun a search for a new CEO. Mr. Papa will remain as CEO and as a member of the bo
- Opus Genetics Expands its Leadership Teamhttps://modernod.com/news/opus-genetics-expands-its-leadership-team/2480981/Opus Genetics, a gene therapy company developing treatments for inherited retinal diseases, announced the appointments of Vikram Arora, PhD, DABT, as Vice President of Non-Clinical Development; Erin O’Neil, MD, as Vice President of Clinical Development; and Sarah Tuller, JD, RAC, as Vice Pr
- NORA Issues Response to Medical Groups' Joint Guidance of Vision Disorders Following a Concussionhttps://modernod.com/news/nora-response-to-medical-groups-joint-guidance-of-vision-disorders-following-a-concussion/2480978/Below is the response from the Neuro Optometric Rehabilitation Association (NORA) regarding the recent statement from various ophthalmic organizations i
- Frontera Therapeutics Completes $160 Million Series B Financing to Fund Clinical Development and Manufacturing Capabilitieshttps://modernod.com/news/frontera-therapeutics-completes-160-million-series-b-financing-to-fund-clinical-development-and-manufacturing-capabilities/2480975/Frontera Therapeutics announced successful completion of a $160 million Series B funding round. In addition, Frontera announced that the FDA has accepted the company’s investigational new drug (IND) application to initiate a first-in-human clinical trial of FT
- Zeiss Ventures Invests in Morrow Eyewearhttps://modernod.com/news/zeiss-ventures-invests-in-morrow-eyewear/2480961/Zeiss Ventures has invested in Morrow, a high-tech start-up from Belgium developing autofocal glasses that allow people to switch between near vision and distance vision at the touch of a button. The innovative liquid crystal technology is embedded between two ultra-precise, thin-c
- Rayner Establishes Direct Presence in Francehttps://modernod.com/news/rayner-establishes-direct-presence-in-france/2480956/Rayner announced its direct entry into the French cataract and refractive market. Based out of Lille in the Hauts-de-France region, Rayner has a growing team of ophthalmic specialist area managers focussed on delivering service and support. Through this team, French ophthalmologist
- Glasgow Eye Department Now Using Ocular Simulation Training Through DRV Systemhttps://modernod.com/news/glasgow-eye-department-now-using-ocular-simulation-training-through-drv-system/2480954/Simulation exposure is now an essential component of the Royal College of Ophthalmologists’ Ophthalmic Specialist Training curriculum prior to real-life surgery, according to a news release from Vision Engineering Group, a maker of ergonomic stereo optical and digital instruments. &nbs